Hospitalizations for respiratory syncytial virus among adults in the United States, 1997-2012

Open Forum Infectious Diseases

Volumn 4, Issue 1, 2017, Pages

  Pastula, Susan T ^a   Hackett, Judith ^b   Coalson, Jenna ^a   Jiang, Xiaohui ^a   Villafana, Tonya ^b   Ambrose, Christopher ^b   Fryzek, Jon ^a  

^a EpidStat Institute   (United States)

^b MEDIMMUNE   (United States)

Author keywords

Adult; Hospitalizations; Respiratory syncytial virus

Indexed keywords

ADULT; ARTICLE; ARTIFICIAL VENTILATION; BRONCHIOLITIS; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HOSPITALIZATION COST; HUMAN; IMMUNOCOMPROMISED PATIENT; INFLUENZA; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RETROSPECTIVE STUDY; UNITED STATES; VIRUS PNEUMONIA;

EID: 85014147734     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/oid/ofw270     Document Type: Article

References (27)

1. Falsey AR, Walsh EE. Respiratory syncytial virus infection in adults. Clin Microbiol Rev 2000; 13:371-84.
2. Falsey AR, Hennessey PA, Formica MA, et al. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 2005; 352:1749-59.
3. Falsey AR, McElhaney JE, Beran J, et al. Respiratory syncytial virus and other respiratory viral infections in older adults with moderate to severe influenza-like illness. J Infect Dis 2014; 209:1873-81.
4. Branche AR, Falsey AR. Respiratory syncytial virus infection in older adults: an under-recognized problem. Drugs Aging 2015; 32:261-9.
5. McManus TE, Marley AM, Baxter N, et al. Respiratory viral infection in exacerbations of COPD. Respir Med 2008; 102:1575-80.
6. Beckham JD, Cadena A, Lin J, et al. Respiratory viral infections in patients with chronic, obstructive pulmonary disease. J Infect 2005; 50:322-30.
7. Camargo CA Jr, Ginde AA, Clark S, et al. Viral pathogens in acute exacerbations of chronic obstructive pulmonary disease. Intern Emerg Med 2008; 3:355-9.
8. De Serres G, Lampron N, La Forge J, et al. Importance of viral and bacterial infections in chronic obstructive pulmonary disease exacerbations. J Clin Virol 2009; 46:129-33.
9. Hutchinson AF, Ghimire AK, Thompson MA, et al. A community-based, timematched, case-control study of respiratory viruses and exacerbations of COPD. Respir Med 2007; 101:2472-81.
10. Mohan A, Chandra S, Agarwal D, et al. Prevalence of viral infection detected by PCR and RT-PCR in patients with acute exacerbation of COPD: a systematic review. Respirology 2010; 15:536-42.
11. Matias G, Taylor R, Haguinet F, et al. Estimates of mortality attributable to influenza and RSV in the United States during 1997-2009 by influenza type or subtype, age, cause of death, and risk status. Influenza Other Respir Viruses 2014; 8:507-15.
12. Nicholson KG. Impact of influenza and respiratory syncytial virus on mortality in England and Wales from January 1975 to December 1990. Epidemiol Infect 1996; 116:51-63.
13. Fleming DM, Taylor RJ, Lustig RL, et al. Modelling estimates of the burden of respiratory syncytial virus infection in adults and the elderly in the United Kingdom. BMC Infect Dis 2015; 15:443.
14. Chan PK, Tam WW, Lee TC, et al. Hospitalization incidence, mortality, and seasonality of common respiratory viruses over a period of 15 years in a developed subtropical city. Medicine (Baltimore) 2015; 94:e2024.
15. Han LL, Alexander JP, Anderson LJ. Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J Infect Dis 1999; 179:25-30.
16. Widmer K, Zhu Y, Williams JV, et al. Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults. J Infect Dis 2012; 206:56-62.
17. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289:179-86.
18. Díez-Domingo J, Pérez-Yarza EG, Melero JA, et al. Social, economic, and health impact of the respiratory syncytial virus: a systematic search. BMC Infect Dis 2014; 14:544.
19. Nicholson KG, Kent J, Hammersley V, Cancio E. Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burden. BMJ 1997; 315:1060-4.
20. Walsh EE, Peterson DR, Falsey AR. Risk factors for severe respiratory syncytial virus infection in elderly persons. J Infect Dis 2004; 189:233-8.
21. Englund JA, Sullivan CJ, Jordan MC, et al. Respiratory syncytial virus infection in immunocompromised adults. Ann Intern Med 1988; 109:203-8.
22. Whimbey E, Champlin RE, Couch RB, et al. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis 1996; 22:778-82.
23. HCUP. Introduction to the HCUP National Inpatient Sample (NIS) 2013: Agency for Healthcare Research and Quality Healthcare Cost and Utilization Project (HCUP), 2015. Available at: http://www.hcup-us.ahrq.gov/db/hcupdatapartners.jsp. Accessed 1 October 2015.
24. AHRQ. AHRQ Quality Indicators: Patient Safety Indicators-Technical Specifications: Department of Health and Human Services, 2006. Available at: http://www.qualityindicators.ahrq.gov/downloads/modules/psi/v30/psi_technical_specs_v30.pdf. Accessed 15 September 2015.
25. Hall CB, Long CE, Schnabel KC. Respiratory syncytial virus infections in previously healthy working adults. Clin Infect Dis 2001; 33:792-6.
26. Prescott WA Jr, Doloresco F, Brown J, Paladino JA. Cost effectiveness of respiratory syncytial virus prophylaxis: a critical and systematic review. Pharmacoeconomics 2010; 28:279-93.
27. Casiano-Colón AE, Hulbert BB, Mayer TK, et al. Lack of sensitivity of rapid antigen tests for the diagnosis of respiratory syncytial virus infection in adults. J Clin Virol 2003; 28:169-74.